直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Patentee in IPR Proceedings Must Establish Patentability of Substitute Claims Over All Prior Art of Record—Not Just Art Cited in Institution Decision

June 29, 2015

Authored and Edited by Abhay A. Watwe, Ph.D.; Elizabeth D. Ferrill; Jeff T. Watson

In Microsoft Corp. v. Proxyconn, Inc., Nos. 14-1542, -1543 (Fed. Cir. June 16, 2015), the Federal Circuit addressed two aspects of inter partes review (IPR) proceedings: (1) the broadest reasonable interpretation standard and (2) requirements for amending claims. First, the Court affirmed the Board’s use of the broadest reasonable interpretation standard, relying on its decision in In re Cuozzo Speed Techs, LLC, 778 F.3d 1271 (Fed. Cir. 2015). The Court cautioned, however, that claim interpretation under this standard cannot be unreasonably broad and must reasonably reflect the plain language and disclosure.

With respect to the requirements for amending claims during IPR, the Court affirmed the Board’s decision to require a showing that the amended claims are patentable over all prior art of record—not just prior art that the Board relied upon when instituting review. The Court explained that if the patentee were not required to establish patentability over all prior art of record, the amended claims could issue even though the PTO had before it prior art that undermined the patentability of the amended claims.

Tags

Patent Trial and Appeal Board (PTAB)

Contacts

Abhay A. Watwe, Ph.D.
Of Counsel
Reston, VA
+1 571 203 2716
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP